CompletedPhase 2

The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training.

Greece35 participantsStarted 2022-11-01

Plain-language summary

The combination of the Integrated Psychological Therapy and Metacognitive Training in individuals with schizophrenia and treatment resistant schizophrenia. Is it effective and efficacious?

Who can participate

Age range19 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of schizophrenia * No relapse and hospitalization * Ambulant psychiatric treatment Exclusion Criteria: * Other psychotic disorders * Relapse and hospitalization * Substance abuse

What they're measuring

Cognitive Functions: Matrics Consensus Cognitive Battery (MCCB), Greek Verbal Test

Timeframe: Baseline T1 (preintervention)-follow-up T3 (after 6 months, up to 55 weeks)

Symptoms, PANSS Greek Version

Timeframe: Baseline T1 (preintervention)-follow-up T3 (after 6 months, up to 55 weeks)

Functional Outcome

Timeframe: Baseline T1 (preintervention)-follow-up T3 (after 6 months, up to 55 weeks)

Recovery

Timeframe: Baseline T1 (preintervention)-follow-up T3 (after 6 months, up to 55 weeks)

Trial details

NCT IDNCT05623228

SponsorRakitzi, Stavroula

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-26

Results submitted2024-10-17

View on ClinicalTrials.gov More Schizophrenia trials